レジオネラ菌検査市場：検査タイプ（培養、尿中抗原検査、DFA、PCR）、用途（水質検査、体外診断（尿、血液））、エンドユーザー（病院、診療所、診断ラボ、水処理産業）、地域別 - 2027年までの世界予測

Legionella Testing Market by Test Type (Culture, Urinary Antigen Test, DFA, PCR), Application (Water & IVD Testing (Urine, Blood)), End User (Hospitals, Clinics, Diagnostic Labs, Water Treatment Industries), Region - Global Forecast to 2027

レジオネラ菌検査の世界市場は、2022年の2億9600万米ドルから2027年には4億3900万米ドルに達すると予測され、予測期間中のCAGRは8.2％となります。この市場の成長は主に、レジオネラ関連疾患の有病率の上昇と相ま... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2022年8月17日	US$4,950 シングルユーザライセンスライセンス・価格情報注文方法はこちら	203	193	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

レジオネラ菌検査の世界市場は、2022年の2億9600万米ドルから2027年には4億3900万米ドルに達すると予測され、予測期間中のCAGRは8.2％となります。この市場の成長は主に、レジオネラ関連疾患の有病率の上昇と相まって老年人口が増加していることと、迅速な診断に対する需要が高まっていることに起因しています。
"レジオネラ菌検査市場の検査タイプ別では、予測期間中、PCRセグメントが最も高い成長率を占めた。"
レジオネラ菌検査市場は、製品により培養法、尿中抗原検査、直接蛍光抗体検査、PCRに分類されます。2021年のレジオネラ菌検査市場では、PCR分野が最も高い成長率を占めています。市場の成長は、そのスピード、汎用性、簡便性に大きく起因しています。
"水・その他産業セグメントが最も高いCAGRを占めた"
レジオネラ菌検査市場は、エンドユーザーに基づいて、病院、診断研究所、水＆その他の産業、その他のエンドユーザーに区分されています。2021年には、水およびその他の産業セグメントが最も高い成長率を占めました。これは、人口の増加や都市化、新たな水資源に対する需要の増加などが要因として挙げられます
"アジア太平洋地域 "です。最も成長率の高い地域レジオネラ菌検査市場"
世界のレジオネラ菌検査市場は、北米、欧州、アジア太平洋地域、中南米、中東・アフリカに区分されます。アジア太平洋地域は、予測期間中に最も高いCAGRを記録すると予測されています。病気の早期診断や定期的な健康診断に関する意識を高めるための政府の取り組みなどの要因

本レポートのために実施した主なインタビューは以下のように分類されます。

- 企業タイプ別企業タイプ別：Tier1 - 40%、Tier2 - 30%、Tier3 - 30
- 役職別Cレベル：27％、Dレベル：18％、その他：55
- 地域別北米：51％、欧州：21％、アジア太平洋：18％、中南米：6％、中東・アフリカ：4
レポート掲載企業リスト

- サーモフィッシャーサイエンティフィック社（米国）
- メルクKGaA（ドイツ）
- バイオ・ラッド・ラボラトリーズ（米国）
- IDEXX Laboratories, Inc.（米国）
- ビオメリュー社（フランス）
- ベクトン・ディッキンソンアンドカンパニー（米国）
- Alere, Inc.(米国)
- ユーロフィン・サイエンティフィック（ルクセンブルグ）
- ロシュ・ダイアグノスティックス（スイス）
- ポール・コーポレーション（ダナハー）（米国）
- Quidel Corporation（米国）
- 栄研化学株式会社（日本(日本)
- ホロジック・インク（米国）
- QIAGEN（ドイツ）
- タカラバイオ株式会社（日本）
- エンバイロメンタルセイフティテクノロジーズ社（米国）
- ハイドロセンス（スコットランド）
- アクセプタ社（イギリス(イギリス)
- LuminUltra Technologies Ltd.(カナダ)
- プロラボ・ダイアグノスティックス社（カナダ）
- バイオアラート・ソリューションズ（カナダ）
- パシフィック・ウォーター・テクノロジー社（オーストラリア）
- アクアサート社（イギリス(イギリス)
- DTKウォーター（イギリス）
- センスソリューションズ（スペイン）
- ジェノマディックス社(アメリカ)
- Phigenics, LLC(米国)。
調査対象範囲
本レポートは、世界のレジオネラ検査市場の詳細図を提供します。検査タイプ、アプリケーション、エンドユーザー、地域など、さまざまなセグメントにわたる市場規模と将来の成長可能性を推定することを目的としています。また、主要な市場プレイヤーの詳細な競合分析、企業プロファイル、最近の開発、主要な市場戦略も掲載しています。

レポート購入の主なメリット
本レポートは、レジオネラ菌検査市場全体とそのサブセグメントに関する収益数の最も近い概算を提供することで、市場リーダー/新規参入者の助けとなります。また、利害関係者が競争環境をよりよく理解し、自社のビジネスをよりよく位置づけ、適切な市場参入戦略を立てるためのより多くの洞察を得るのに役立ちます。本レポートは、利害関係者が市場の脈動を理解し、主要な市場促進要因、阻害要因、機会、および課題に関する情報を提供することを可能にするものです。

ページTOPに戻る

1 INTRODUCTION 27
1.1 STUDY OBJECTIVES 27
1.2 MARKET DEFINITION 27
TABLE 1 INCLUSIONS AND EXCLUSIONS 27
1.3 STUDY SCOPE 28
1.4 YEARS CONSIDERED 28
1.5 CURRENCY CONSIDERED 29
1.6 LIMITATIONS 29
1.7 STAKEHOLDERS 29
2 RESEARCH METHODOLOGY 30
2.1 RESEARCH DATA 30
FIGURE 1 LEGIONELLA TESTING MARKET: RESEARCH DESIGN METHODOLOGY 30
2.1.1 SECONDARY DATA 31
2.1.1.1 Key data from secondary sources 31
2.1.2 PRIMARY DATA 32
2.1.2.1 Key data from primary sources 33
TABLE 2 KEY DATA FROM PRIMARY SOURCES 33
FIGURE 2 KEY INDUSTRY INSIGHTS 34
2.1.2.2 Breakdown of primary interviews 34
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS (LEGIONELLA TESTING MARKET) 34
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 35
2.2 MARKET SIZE ESTIMATION 35
2.2.1 BOTTOM-UP APPROACH 36
2.2.1.1 Approach 1: Company revenue estimation approach 36
FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 36
2.2.1.2 Approach 2: Presentations of companies and primary interviews 36
2.2.1.3 Growth forecast 37
2.2.1.4 CAGR projections 37
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 37
2.2.2 TOP-DOWN APPROACH 38
FIGURE 7 LEGIONELLA TESTING MARKET: TOP-DOWN APPROACH 38
2.3 DATA TRIANGULATION 39
FIGURE 8 DATA TRIANGULATION METHODOLOGY 39
2.4 RESEARCH ASSUMPTIONS 40
2.5 LIMITATIONS AND RISK ASSESSMENT 40
FIGURE 9 LIMITATIONS: LEGIONELLA TESTING MARKET 40
TABLE 3 RISK ASSESSMENT: LEGIONELLA TESTING MARKET 41
3 EXECUTIVE SUMMARY 42
FIGURE 10 LEGIONELLA TESTING MARKET, BY TEST TYPE, 2022 VS. 2027 (USD MILLION) 42
FIGURE 11 LEGIONELLA TESTING MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 43
FIGURE 12 LEGIONELLA TESTING MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 43
FIGURE 13 LEGIONELLA TESTING MARKET, BY REGION, 2022 VS. 2027 (USD MILLION) 44
4 PREMIUM INSIGHTS 45
4.1 LEGIONELLA TESTING MARKET OVERVIEW 45
FIGURE 14 GROWING PREVALENCE OF LEGIONELLA-RELATED ILLNESS AND RISING GERIATRIC POPULATION TO DRIVE MARKET GROWTH 45
4.2 LEGIONELLA TESTING MARKET SHARE, BY TEST TYPE, 2022 VS. 2027 46
FIGURE 15 PCR SEGMENT WILL CONTINUE TO DOMINATE MARKET IN 2027 46
4.3 LEGIONELLA TESTING MARKET SHARE, BY APPLICATION, 2022 VS. 2027 46
FIGURE 16 WATER TESTING SEGMENT TO HOLD LARGEST MARKET SHARE 46
4.4 LEGIONELLA TESTING MARKET SHARE, BY END USER, 2022 VS. 2027 47
FIGURE 17 WATER & OTHER INDUSTRIES TO CONTINUE TO DOMINATE MARKET IN 2027 47
4.5 LEGIONELLA TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 47
FIGURE 18 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE 47
5 MARKET OVERVIEW 48
5.1 INTRODUCTION 48
5.2 MARKET DYNAMICS 48
FIGURE 19 LEGIONELLA TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 48
5.2.1 DRIVERS 49
5.2.1.1 Rising incidence of pneumonia and legionella-related illnesses 49
5.2.1.2 Increasing demand for rapid advanced diagnostic technologies 49
5.2.1.3 Technological advancements in bacterial testing 49
5.2.1.4 Stringent regulations for regular water testing 50
5.2.2 RESTRAINTS 51
5.2.2.1 Lack of reimbursement policies 51
5.2.3 OPPORTUNITIES 51
5.2.3.1 Opportunities in growing economies 51
5.2.3.2 Legal requirements for water testing 51
5.2.4 CHALLENGES 52
5.2.4.1 Difficulties in detection 52
5.2.4.2 Limited awareness in underdeveloped countries 52
5.2.4.3 High health costs associated with Legionella 53
5.3 PRICING ANALYSIS 53
TABLE 4 AVERAGE SELLING PRICE OF LEGIONELLA TESTING PRODUCTS (2022) 53
5.4 PATENT ANALYSIS 54
FIGURE 20 PATENT ANALYSIS FOR MOTORIZED LEGIONELLA TESTING DEVICES 54
TABLE 5 LIST OF KEY PATENTS 55
5.5 VALUE CHAIN ANALYSIS 57
FIGURE 21 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING MANUFACTURING AND ASSEMBLY PHASES 57
5.6 SUPPLY CHAIN ANALYSIS 58
FIGURE 22 LEGIONELLA TESTING MARKET: SUPPLY CHAIN ANALYSIS 58
5.7 ECOSYSTEM/MARKET MAP 59
FIGURE 23 LEGIONELLA TESTING MARKET: ECOSYSTEM/MARKET MAP 59
TABLE 6 LEGIONELLA TESTING MARKET: ROLE IN ECOSYSTEM 60
5.8 PORTER’S FIVE FORCES ANALYSIS 60
TABLE 7 LEGIONELLA TESTING MARKET: PORTER’S FIVE FORCES ANALYSIS 60
5.8.1 THREAT OF NEW ENTRANTS 61
5.8.2 THREAT OF SUBSTITUTES 61
5.8.3 BARGAINING POWER OF BUYERS 61
5.8.4 BARGAINING POWER OF SUPPLIERS 61
5.8.5 DEGREE OF COMPETITION 61
5.9 PESTEL ANALYSIS 62
5.9.1 POLITICAL FACTORS 62
5.9.2 ECONOMIC FACTORS 62
5.9.3 SOCIAL FACTORS 62
5.9.4 TECHNOLOGICAL FACTORS 63
5.9.5 ENVIRONMENTAL FACTORS 63
5.9.6 LEGAL FACTORS 63
5.10 REGULATORY LANDSCAPE 64
TABLE 8 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 64
TABLE 9 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 65
TABLE 10 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 65
TABLE 11 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 66
TABLE 12 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 66
5.10.1 NORTH AMERICA 66
5.10.1.1 US 66
5.10.1.2 Canada 67
5.10.2 EUROPE 67
5.10.3 ASIA PACIFIC 67
5.10.3.1 Japan 67
5.10.3.2 India 67
5.10.4 LATIN AMERICA 68
5.10.4.1 Brazil 68
5.10.4.2 Mexico 68
5.10.5 MIDDLE EAST 68
5.10.6 AFRICA 69
5.11 TRADE ANALYSIS 69
5.11.1 TRADE ANALYSIS FOR DIAGNOSTIC AND LABORATORY REAGENTS 69
TABLE 13 IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2017–2021 (USD MILLION) 69
TABLE 14 EXPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2017–2021 (USD MILLION) 69
5.12 TECHNOLOGY ANALYSIS 70
5.13 KEY CONFERENCES & EVENTS IN 2022–2023 71
TABLE 15 LEGIONELLA TESTING MARKET: DETAILED LIST OF CONFERENCES & EVENTS 71
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 72
FIGURE 24 REVENUE SHIFT IN THE LEGIONELLA TESTING MARKET 72
5.15 KEY STAKEHOLDERS & BUYING CRITERIA 72
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 72
FIGURE 25 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF LEGIONELLA TESTING PRODUCTS 72
TABLE 16 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF LEGIONELLA TESTING PRODUCTS 73
5.15.2 BUYING CRITERIA 73
FIGURE 26 KEY BUYING CRITERIA FOR LEGIONELLA TESTING PRODUCTS 73
TABLE 17 KEY BUYING CRITERIA FOR LEGIONELLA TESTING PRODUCTS 73
5.16 CASE STUDIES 74
6 LEGIONELLA TESTING MARKET, BY TEST TYPE 75
6.1 INTRODUCTION 76
TABLE 18 LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION) 76
6.2 PCR 76
6.2.1 INCREASED USAGE OF PCR TO SUPPORT MARKET GROWTH 76
TABLE 19 KEY PCR PRODUCTS AVAILABLE IN THE MARKET 77
TABLE 20 LEGIONELLA TESTING MARKET FOR PCR, BY REGION, 2020–2027 (USD MILLION) 77
6.3 CULTURE METHODS 77
6.3.1 HIGHER SPECIFICITY AND SENSITIVITY TO DRIVE MARKET 77
TABLE 21 KEY CULTURE METHODS AVAILABLE IN THE MARKET 78
TABLE 22 LEGIONELLA TESTING MARKET FOR CULTURE METHODS, BY REGION, 2020–2027 (USD MILLION) 79
6.4 URINARY ANTIGEN TESTS 79
6.4.1 RAPID OUTCOMES TO DRIVE MARKET GROWTH 79
TABLE 23 KEY URINARY ANTIGEN TESTS AVAILABLE IN THE MARKET 79
TABLE 24 LEGIONELLA TESTING MARKET FOR URINARY ANTIGEN TESTS, BY REGION, 2020–2027 (USD MILLION) 80
6.5 DIRECT FLUORESCENT ANTIBODY TESTS 80
6.5.1 RAPIDITY AND EASE OF USE TO BOOST ADOPTION OF TESTS 80
TABLE 25 LEGIONELLA TESTING MARKET FOR DIRECT FLUORESCENT ANTIBODY TESTS, BY REGION, 2020–2027 (USD MILLION) 80
7 LEGIONELLA TESTING MARKET, BY APPLICATION 81
7.1 INTRODUCTION 82
TABLE 26 LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 82
7.2 WATER TESTING 82
TABLE 27 LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION) 83
TABLE 28 LEGIONELLA TESTING MARKET FOR WATER TESTING, BY REGION, 2020–2027 (USD MILLION) 83
7.2.1 PCR 83
7.2.1.1 Rapid diagnosis to spur segment growth 83
TABLE 29 WATER TESTING MARKET FOR PCR, BY REGION, 2020–2027 (USD MILLION) 84
7.2.2 MICROBIAL CULTURE 84
7.2.2.1 Long incubation periods make isolation difficult, affecting adoption of culture techniques 84
TABLE 30 WATER TESTING MARKET FOR MICROBIAL CULTURE, BY REGION, 2020–2027 (USD MILLION) 85
7.2.3 DFA STAIN 85
7.2.3.1 High test specificity to drive adoption of DFA staining 85
TABLE 31 WATER TESTING MARKET FOR DFA STAIN, BY REGION, 2020–2027 (USD MILLION) 86
7.3 IVD TESTING 86
TABLE 32 LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION) 86
TABLE 33 LEGIONELLA TESTING MARKET FOR IVD TESTING, BY REGION, 2020–2027 (USD MILLION) 87
7.3.1 URINE ANTIGEN TESTS 87
7.3.1.1 Rapid and early diagnosis capabilities to drive market growth 87
TABLE 34 IVD TESTING MARKET FOR URINE ANTIGEN TESTS, BY REGION, 2020–2027 (USD MILLION) 88
7.3.2 PCR 88
7.3.2.1 Emergence of advanced technologies such as qRT-PCR to support market growth 88
TABLE 35 IVD TESTING MARKET FOR PCR, BY REGION, 2020–2027 (USD MILLION) 88
7.3.3 BLOOD CULTURE & SPUTUM TESTS 89
7.3.3.1 Longer incubation period resulting in lower adoption of blood culture techniques 89
TABLE 36 IVD TESTING MARKET FOR BLOOD CULTURE & SPUTUM TESTS, BY REGION, 2020–2027 (USD MILLION) 89
7.3.4 DFA STAIN 90
7.3.4.1 Sensitivity variations affect use of DFA staining in IVD tests 90
TABLE 37 IVD TESTING MARKET FOR DFA STAIN, BY REGION, 2020–2027 (USD MILLION) 90
7.4 OTHER APPLICATIONS 90
TABLE 38 LEGIONELLA TESTING MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 91
8 LEGIONELLA TESTING MARKET, BY END USER 92
8.1 INTRODUCTION 93
TABLE 39 LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 93
8.2 WATER & OTHER INDUSTRIES 93
8.2.1 STRINGENT REGULATIONS AND GROWING POPULATION TO DRIVE MARKET GROWTH 93
TABLE 40 LEGIONELLA TESTING MARKET FOR WATER & OTHER INDUSTRIES, BY REGION, 2020–2027 (USD MILLION) 94
8.3 DIAGNOSTIC LABORATORIES 94
8.3.1 HEALTHCARE INFRASTRUCTURE IMPROVEMENTS TO BOOST MARKET GROWTH 94
TABLE 41 LEGIONELLA TESTING MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2020–2027 (USD MILLION) 95
8.4 HOSPITALS 95
8.4.1 INCREASING ADOPTION OF DIAGNOSTIC TOOLS TO SUPPORT MARKET GROWTH 95
TABLE 42 LEGIONELLA TESTING MARKET FOR HOSPITALS, BY REGION, 2020–2027 (USD MILLION) 96
8.5 OTHER END USERS 96
TABLE 43 LEGIONELLA TESTING MARKET FOR OTHER END USERS, BY REGION, 2020–2027 (USD MILLION) 96
9 LEGIONELLA TESTING MARKET, BY REGION 97
9.1 INTRODUCTION 98
TABLE 44 LEGIONELLA TESTING MARKET, BY REGION, 2020–2027 (USD MILLION) 98
9.2 NORTH AMERICA 98
FIGURE 27 NORTH AMERICA: LEGIONELLA TESTING MARKET SNAPSHOT 99
TABLE 45 NORTH AMERICA: LEGIONELLA TESTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 99
TABLE 46 NORTH AMERICA: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION) 100
TABLE 47 NORTH AMERICA: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 100
TABLE 48 NORTH AMERICA: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 100
9.2.1 US 101
9.2.1.1 Strong presence of major market players to drive growth 101
TABLE 49 US: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION) 101
TABLE 50 US: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 101
TABLE 51 US: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION) 102
TABLE 52 US: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION) 102
TABLE 53 US: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 102
9.2.2 CANADA 103
9.2.2.1 Rising incidence of lifestyle diseases to drive market growth 103
TABLE 54 CANADA: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION) 103
TABLE 55 CANADA: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 103
TABLE 56 CANADA: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION) 104
TABLE 57 CANADA: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION) 104
TABLE 58 CANADA: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 104
9.3 EUROPE 105
TABLE 59 EUROPE: LEGIONELLA TESTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 105
TABLE 60 EUROPE: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION) 106
TABLE 61 EUROPE: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 106
TABLE 62 EUROPE: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 106
9.3.1 GERMANY 107
9.3.1.1 Germany dominates Legionella testing market in Europe 107
TABLE 63 GERMANY: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION) 107
TABLE 64 GERMANY: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 107
TABLE 65 GERMANY: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION) 108
TABLE 66 GERMANY: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION) 108
TABLE 67 GERMANY: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 108
9.3.2 UK 109
9.3.2.1 Growing number of accredited diagnostic laboratories to propel market growth 109
TABLE 68 UK: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION) 109
TABLE 69 UK: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 110
TABLE 70 UK: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION) 110
TABLE 71 UK: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION) 110
TABLE 72 UK: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 111
9.3.3 FRANCE 111
9.3.3.1 Rising R&D expenditure and increasing demand for early diagnosis to drive market growth 111
TABLE 73 FRANCE: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION) 111
TABLE 74 FRANCE: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 112
TABLE 75 FRANCE: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 76 FRANCE: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 77 FRANCE: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 113
9.3.4 ITALY 113
9.3.4.1 Adoption of advanced diagnostic technologies to drive market growth 113
TABLE 78 ITALY: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION) 114
TABLE 79 ITALY: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 114
TABLE 80 ITALY: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 81 ITALY: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION) 115
TABLE 82 ITALY: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 115
9.3.5 SPAIN 115
9.3.5.1 Rising geriatric population to drive market growth 115
TABLE 83 SPAIN: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION) 116
TABLE 84 SPAIN: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 116
TABLE 85 SPAIN: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION) 117
TABLE 86 SPAIN: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION) 117
TABLE 87 SPAIN: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 117
9.3.6 REST OF EUROPE 118
TABLE 88 ROE: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION) 118
TABLE 89 ROE: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 119
TABLE 90 ROE: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION) 119
TABLE 91 ROE: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION) 119
TABLE 92 ROE: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 120
9.4 ASIA PACIFIC 120
FIGURE 28 APAC: LEGIONELLA TESTING MARKET SNAPSHOT 121
TABLE 93 ASIA PACIFIC: LEGIONELLA TESTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 122
TABLE 94 ASIA PACIFIC: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION) 122
TABLE 95 ASIA PACIFIC: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 122
TABLE 96 ASIA PACIFIC: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 123
9.4.1 CHINA 123
9.4.1.1 Growing public access to modern healthcare to drive market growth 123
TABLE 97 CHINA: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION) 124
TABLE 98 CHINA: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 99 CHINA: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION) 124
TABLE 100 CHINA: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 101 CHINA: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 125
9.4.2 JAPAN 125
9.4.2.1 Universal healthcare reimbursement policy to drive market growth 125
TABLE 102 JAPAN: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION) 126
TABLE 103 JAPAN: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 126
TABLE 104 JAPAN: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION) 127
TABLE 105 JAPAN: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION) 127
TABLE 106 JAPAN: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 127
9.4.3 INDIA 128
9.4.3.1 Increasing private & public investments in healthcare to drive market growth 128
TABLE 107 INDIA: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION) 128
TABLE 108 INDIA: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 129
TABLE 109 INDIA: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION) 129
TABLE 110 INDIA: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION) 129
TABLE 111 INDIA: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 130
9.4.4 REST OF ASIA PACIFIC 130
TABLE 112 ROAPAC: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION) 131
TABLE 113 ROAPAC: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 114 ROAPAC: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION) 131
TABLE 115 ROAPAC: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 116 ROAPAC: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 132
9.5 LATIN AMERICA 132
9.5.1 RISING HEALTHCARE EXPENDITURE TO DRAW FOREIGN PLAYERS 132
TABLE 117 LATIN AMERICA: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION) 133
TABLE 118 LATIN AMERICA: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 133
TABLE 119 LATIN AMERICA: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 134
9.6 MIDDLE EAST & AFRICA 134
9.6.1 RISING ACCESS TO ADVANCED TECHNOLOGIES AND GROWING INVESTMENTS TO SUPPORT MARKET GROWTH 134
TABLE 120 MIDDLE EAST & AFRICA: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION) 135
TABLE 121 MIDDLE EAST & AFRICA: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 135
TABLE 122 MIDDLE EAST & AFRICA: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 135
10 COMPETITIVE LANDSCAPE 136
10.1 OVERVIEW 136
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 136
10.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN THE LEGIONELLA TESTING MARKET 136
TABLE 123 STRATEGIC DEVELOPMENTS REPORTED 136
10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 137
FIGURE 29 REVENUE SHARE ANALYSIS OF TOP PLAYERS 137
10.4 MARKET SHARE ANALYSIS 138
10.4.1 LEGIONELLA TESTING MARKET 138
FIGURE 30 LEGIONELLA TESTING MARKET SHARE, BY KEY PLAYER (2021) 138
TABLE 124 LEGIONELLA TESTING MARKET: DEGREE OF COMPETITION 139
10.5 COMPANY EVALUATION MATRIX 140
10.5.1 LIST OF EVALUATED VENDORS 140
10.5.2 STARS 140
10.5.3 EMERGING LEADERS 140
10.5.4 PERVASIVE PLAYERS 140
10.5.5 PARTICIPANTS 140
FIGURE 31 LEGIONELLA TESTING MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021 141
10.6 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2021) 142
10.6.1 PROGRESSIVE COMPANIES 142
10.6.2 STARTING BLOCKS 142
10.6.3 RESPONSIVE COMPANIES 142
10.6.4 DYNAMIC COMPANIES 142
FIGURE 32 LEGIONELLA TESTING MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES, 2021 143
10.7 COMPETITIVE BENCHMARKING 144
10.7.1 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS 144
FIGURE 33 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN LEGIONELLA TESTING MARKET 144
TABLE 125 LEGIONELLA TESTING MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS 144
TABLE 126 PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS 145
TABLE 127 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS 145
TABLE 128 LEGIONELLA TESTING MARKET: DETAILED LIST OF KEY START-UPS/SMES 145
10.8 COMPETITIVE SCENARIO 146
10.8.1 PRODUCT LAUNCHES 146
TABLE 129 LEGIONELLA TESTING MARKET: KEY PRODUCT LAUNCHES & REGULATORY APPROVALS 146
10.8.2 DEALS 146
TABLE 130 LEGIONELLA TESTING MARKET: KEY DEALS 146
10.8.3 OTHER DEVELOPMENTS 147
TABLE 131 LEGIONELLA TESTING MARKET: OTHER DEVELOPMENTS 147
11 COMPANY PROFILES 148
(Business Overview, Products Offered, Recent Developments, MnM View SWOT analysis) *
11.1 KEY PLAYERS 148
11.1.1 INDUSTRIAL/WATER 148
11.1.1.1 Thermo Fisher Scientific 148
TABLE 132 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW 148
FIGURE 34 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2021) 149
11.1.1.2 Merck KGAA 152
TABLE 133 MERCK KGAA: BUSINESS OVERVIEW 152
FIGURE 35 MERCK KGAA: COMPANY SNAPSHOT (2021) 153
11.1.1.3 Bio-Rad Laboratories 156
TABLE 134 BIO-RAD LABORATORIES: BUSINESS OVERVIEW 156
FIGURE 36 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2021) 157
11.1.1.4 IDEXX Laboratories 159
TABLE 135 IDEXX LABORATORIES: BUSINESS OVERVIEW 159
FIGURE 37 IDEXX LABORATORIES: COMPANY SNAPSHOT (2021) 160
11.1.1.5 Biomérieux SA 162
TABLE 136 BIOMÉRIEUX SA: BUSINESS OVERVIEW 162
FIGURE 38 BIOMÉRIEUX SA: COMPANY SNAPSHOT (2021) 163
11.1.1.6 Becton, Dickinson and Company 165
TABLE 137 BECTON, DICKINSON, AND COMPANY: BUSINESS OVERVIEW 165
FIGURE 39 BECTON, DICKINSON, AND COMPANY: COMPANY SNAPSHOT (2021) 166
11.1.1.7 Eurofins Scientific 168
TABLE 138 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW 168
FIGURE 40 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2021) 168
11.1.1.8 Takara Bio 171
TABLE 139 TAKARA BIO: BUSINESS OVERVIEW 171
FIGURE 41 TAKARA BIO: COMPANY SNAPSHOT (2021) 172
11.1.1.9 Eiken Chemical 174
TABLE 140 EIKEN CHEMICAL: BUSINESS OVERVIEW 174
FIGURE 42 EIKEN CHEMICAL: COMPANY SNAPSHOT (2021) 174
11.1.1.10 Qiagen 176
TABLE 141 QIAGEN: BUSINESS OVERVIEW 176
FIGURE 43 QIAGEN: COMPANY SNAPSHOT (2021) 177
11.1.1.11 Genomadix 179
TABLE 142 GENOMADIX, INC.: BUSINESS OVERVIEW 179
11.2 OTHER PLAYERS 180
11.2.1 INDUSTRIAL/WATER 180
11.2.1.1 Pall Corporation (DANAHER) 180
11.2.1.2 Phigenics, Llc 181
11.2.1.3 Environmental safety technologies 182
11.2.1.4 Hydrosense 182
11.2.1.5 Accepta 183
11.2.1.6 Luminultra technologies 183
11.2.1.7 Bioalert solutions 184
11.2.1.8 Aquacert 184
11.2.1.9 Pacific water technology 185
11.2.1.10 DTK Water 186
11.2.1.11 Sens solutions 186
11.2.2 HEALTHCARE 187
11.2.2.1 Alere (ABBOTT) 187
TABLE 143 ABBOTT: BUSINESS OVERVIEW 187
FIGURE 44 ABBOTT: COMPANY SNAPSHOT (2021) 188
11.2.2.2 Roche Diagnostics 190
TABLE 144 ROCHE DIAGNOSTICS: BUSINESS OVERVIEW 190
FIGURE 45 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2021) 191
11.2.2.3 Hologic 194
TABLE 145 HOLOGIC: BUSINESS OVERVIEW 194
FIGURE 46 HOLOGIC: COMPANY SNAPSHOT (2021) 195
11.2.2.4 Quidel Corporation 198
TABLE 146 QUIDEL CORPORATION: BUSINESS OVERVIEW 198
FIGURE 47 QUIDEL CORPORATION: COMPANY SNAPSHOT (2021) 199
11.2.2.5 Pro-Lab Diagnostics 200
*Details on Business Overview, Products Offered, Recent Developments, MnM View, SWOT analysis might not be captured in case of unlisted companies.
12 APPENDIX 201
12.1 DISCUSSION GUIDE 201
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 205
12.3 CUSTOMIZATION OPTIONS 207
12.4 RELATED REPORTS 207
12.5 AUTHOR DETAILS 208

ページTOPに戻る

Table of Contents

Summary

The global legionella testing market is projected to reach USD 439 million by 2027 from USD 296 million in 2022, at a CAGR of 8.2% during the forecast period. Growth in this market is mainly driven by the rising geriatric population coupled with increasing prevalence of legionella-related illness, and rising demand for rapid diagnostics.
"The PCR segment accounted for the highest growth rate in the legionella testing market, by test type, during the forecast period."
The legionella testing market is segmented into culture methods, urinary antigen tests, direct fluorescent antibody tests, and PCR based on product. In 2021, the PCR segment accounted for the highest growth rate in the legionella testing market. Market growth can largely be attributed to its speed, versatility, and simplicity.
"Water & Other Industries segment accounted for the highest CAGR."
Based on the end user, the legionella testing market has been segmented into hospitals, diagnostic laboratories, water & other industries, and other end user. In 2021, the water & other industries segment accounted for the highest growth rate. This can be attributed to the rising population and urbanization, and the increased demand for new water resources
"Asia Pacific: The fastest-growing region legionella testing market."
The global legionella testing market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period. Factors such as government efforts to increase awareness about the early disease diagnosis and regular health check-ups

The primary interviews conducted for this report can be categorized as follows:

• By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 -30%
• By Designation: C-level - 27%, D-level - 18%, and Others - 55%
• By Region: North America -51%, Europe - 21%, Asia Pacific - 18%, Latin America – 6%, and the Middle East & Africa – 4%
Lists of Companies Profiled in the Report:

• Thermo Fisher Scientific, Inc. (US)
• Merck KGaA (Germany)
• Bio-Rad Laboratories, Inc. (US)
• IDEXX Laboratories, Inc. (US)
• bioMérieux S.A. (France)
• Becton, Dickinson, and Company (US)
• Alere, Inc. (US)
• Eurofins Scientific (Luxembourg)
• Roche Diagnostics (Switzerland)
• Pall Corporation (Danaher) (US)
• Quidel Corporation (US)
• Eiken Chemical Co., Ltd. (Japan)
• Hologic, Inc. (US)
• QIAGEN (Germany)
• Takara Bio, Inc. (Japan)
• Environmental Safety Technologies, Inc. (US)
• Hydrosense (Scotland)
• Accepta Ltd. (UK)
• LuminUltra Technologies Ltd. (Canada)
• Pro-Lab Diagnostics, Inc. (Canada)
• BioAlert Solutions (Canada)
• Pacific Water Technology (Australia)
• Aquacert Ltd. (UK)
• DTK Water (UK)
• Sens Solutions (Spain)
• Genomadix, Inc. (US)
• Phigenics, LLC (US).
Research Coverage:
This report provides a detailed picture of the global legionella testingmarket. It aims at estimating the size and future growth potential of the market across different segments, such as test type, application, end user, and region. The report also includes an in-depth competitive analysis of the key market player, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall legionella testing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（在宅・地域医療）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（clinics）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

レジオネラ菌検査市場：検査タイプ（培養、尿中抗原検査、DFA、PCR）、用途（水質検査、体外診断（尿、血液））、エンドユーザー（病院、診療所、診断ラボ、水処理産業）、地域別 - 2027年までの世界予測

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（在宅・地域医療）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（clinics）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?